| Molecular mechanisms of resistance and toxicity associated with platinating agents CA Rabik, ME Dolan Cancer treatment reviews 33 (1), 9-23, 2007 | 1969 | 2007 |
| Expansion of the Gene Ontology knowledgebase and resources Gene Ontology Consortium Nucleic acids research 45 (D1), D331-D338, 2017 | 1751* | 2017 |
| Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS DL Nicolae, E Gamazon, W Zhang, S Duan, ME Dolan, NJ Cox PLoS genetics 6 (4), e1000888, 2010 | 1491 | 2010 |
| The gene ontology (GO) project in 2006 Gene Ontology Consortium Nucleic acids research 34 (suppl_1), D322-D326, 2006 | 836 | 2006 |
| Human polymorphism at microRNAs and microRNA target sites MA Saunders, H Liang, WH Li Proceedings of the National Academy of Sciences 104 (9), 3300-3305, 2007 | 783 | 2007 |
| Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase AE Pegg, ME Dolan, RC Moschel Progress in nucleic acid research and molecular biology 51, 167-223, 1995 | 673 | 1995 |
| Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against … ME Dolan, RC Moschel, AE Pegg Proceedings of the National Academy of Sciences 87 (14), 5368-5372, 1990 | 552 | 1990 |
| Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2 R Humerickhouse, K Lohrbach, L Li, WF Bosron, ME Dolan Cancer research 60 (5), 1189-1192, 2000 | 445 | 2000 |
| The gene ontology knowledgebase in 2023 SA Aleksander, J Balhoff, S Carbon, JM Cherry, HJ Drabkin, D Ebert, ... Genetics 224 (1), iyad031, 2023 | 376 | 2023 |
| AgBase: a functional genomics resource for agriculture FM McCarthy, N Wang, GB Magee, B Nanduri, ML Lawrence, EB Camon, ... BMC genomics 7, 1-13, 2006 | 346 | 2006 |
| Mouse models of human AML accurately predict chemotherapy response J Zuber, I Radtke, TS Pardee, Z Zhao, AR Rappaport, W Luo, ... Genes & development 23 (7), 877-889, 2009 | 327 | 2009 |
| Testicular cancer survivorship: research strategies and recommendations LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ... Journal of the national cancer institute 102 (15), 1114-1130, 2010 | 325 | 2010 |
| The pharmacogenetics research network: from SNP discovery to clinical drug response KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ... Clinical Pharmacology & Therapeutics 81 (3), 328-345, 2007 | 304 | 2007 |
| Effect of O6-Benzylguanine Analogues on Sensitivity of Human Tumor Cells to the Cytotoxic Effects of Alkylating Agents ME Dolan, RB Mitchell, C Mummert, RC Moschel, AE Pegg Cancer research 51 (13), 3367-3372, 1991 | 302 | 1991 |
| Chemotherapy-induced peripheral neuropathy: Current status and progress JR Brewer, G Morrison, ME Dolan, GF Fleming Gynecologic oncology 140 (1), 176-183, 2016 | 301 | 2016 |
| Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics F Innocenti, DL Kroetz, E Schuetz, ME Dolan, J Ramírez, M Relling, ... Journal of Clinical Oncology 27 (16), 2604, 2009 | 294 | 2009 |
| Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia B Diouf, KR Crews, G Lew, D Pei, C Cheng, J Bao, JJ Zheng, W Yang, ... Jama 313 (8), 815-823, 2015 | 292 | 2015 |
| O6-benzylguanine and its role in chemotherapy. ME Dolan, AE Pegg Clinical cancer research: an official journal of the American Association …, 1997 | 291 | 1997 |
| Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer EE Vokes, MS Kies, DJ Haraf, K Stenson, M List, R Humerickhouse, ... Journal of Clinical Oncology 18 (8), 1652-1661, 2000 | 283 | 2000 |
| SCAN: SNP and copy number annotation ER Gamazon, W Zhang, A Konkashbaev, S Duan, EO Kistner, DL Nicolae, ... Bioinformatics 26 (2), 259-262, 2010 | 277 | 2010 |
